These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 17287089)

  • 1. Assessment of motivation to change substance use in dually-diagnosed schizophrenia patients.
    Kinnaman JE; Bellack AS; Brown CH; Yang Y
    Addict Behav; 2007 Sep; 32(9):1798-813. PubMed ID: 17287089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurocognitive characteristics of individuals with schizophrenia and cocaine dependence: comparison of currently dependent and remitted groups.
    Peer J; Bennett ME; Bellack AS
    J Nerv Ment Dis; 2009 Aug; 197(8):631-4. PubMed ID: 19684503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders.
    Barrowclough C; Haddock G; Tarrier N; Lewis SW; Moring J; O'Brien R; Schofield N; McGovern J
    Am J Psychiatry; 2001 Oct; 158(10):1706-13. PubMed ID: 11579006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using measures of readiness to change in individuals with schizophrenia.
    Addington J; el-Guebaly N; Duchak V; Hodgins D
    Am J Drug Alcohol Abuse; 1999 Feb; 25(1):151-61. PubMed ID: 10078983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Motivation and the stages of change among individuals with severe mental illness and substance abuse disorders.
    DiClemente CC; Nidecker M; Bellack AS
    J Subst Abuse Treat; 2008 Jan; 34(1):25-35. PubMed ID: 17574798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of the University of Rhode Island Change Assessment to measure motivational readiness to change in psychiatric and dually diagnosed individuals.
    Pantalon MV; Swanson AJ
    Psychol Addict Behav; 2003 Jun; 17(2):91-7. PubMed ID: 12814272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurocognitive dysfunction in dually-diagnosed patients: a potential roadblock to motivating behavior change.
    Blume AW; Davis JM; Schmaling KB
    J Psychoactive Drugs; 1999; 31(2):111-5. PubMed ID: 10437992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders.
    Brunette MF; Noordsy DL; Xie H; Drake RE
    Psychiatr Serv; 2003 Oct; 54(10):1395-401. PubMed ID: 14557527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Working memory and depressive symptoms in patients with schizophrenia and substance use disorders.
    Potvin S; Pampoulova T; Lipp O; Ait Bentaleb L; Lalonde P; Stip E
    Cogn Neuropsychiatry; 2008 Jul; 13(4):357-66. PubMed ID: 18622790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychopathology and Wisconsin Card Sorting Test performance in male schizophrenic patients: influence of dual diagnosis.
    Rodriguez-Jimenez R; Aragües M; Jimenez-Arriero MA; Ponce G; Martinez I; Hoenicka J; Rubio G; Palomo T;
    Psychopathology; 2008; 41(1):58-64. PubMed ID: 17975329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug abuse and/or dependence and better neuropsychological performance in patients with schizophrenia.
    Joyal CC; Hallé P; Lapierre D; Hodgins S
    Schizophr Res; 2003 Oct; 63(3):297-9. PubMed ID: 12957709
    [No Abstract]   [Full Text] [Related]  

  • 12. Substance abuse and cognitive functioning in schizophrenia.
    Addington J; Addington D
    J Psychiatry Neurosci; 1997 Mar; 22(2):99-104. PubMed ID: 9074303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does motivation to change mediate the effect of DSM-IV substance use disorders on treatment utilization and substance use?
    Carpenter KM; Miele GM; Hasin DS
    Addict Behav; 2002; 27(2):207-25. PubMed ID: 11817763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive impairment in schizophrenia: clinical ratings are not a suitable alternative to neuropsychological testing.
    Hofer A; Niedermayer B; Kemmler G; Rettenbacher MA; Trebo E; Widschwendter CG; Fleischhacker WW
    Schizophr Res; 2007 May; 92(1-3):126-31. PubMed ID: 17350807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substance dependence and remission in schizophrenia: A comparison of schizophrenia and affective disorders.
    Bennett ME; Bellack AS; Brown CH; DiClemente C
    Addict Behav; 2009 Oct; 34(10):806-14. PubMed ID: 19375237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novelty-seeking among schizophrenia patients with comorbid alcohol abuse.
    Kim JH; Kim D; Park SH; Lee HB; Chung EK
    J Nerv Ment Dis; 2007 Jul; 195(7):622-4. PubMed ID: 17632255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Examination of contingency payments to dually-diagnosed patients in a multi-faceted behavioral treatment.
    Strong Kinnaman JE; Slade E; Bennett ME; Bellack AS
    Addict Behav; 2007 Jul; 32(7):1480-5. PubMed ID: 17098369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring readiness-to-change substance misuse among psychiatric outpatients: I. Reliability and validity of self-report measures.
    Carey KB; Maisto SA; Carey MP; Purnine DM
    J Stud Alcohol; 2001 Jan; 62(1):79-88. PubMed ID: 11271968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of sex to symptom severity, psychiatric comorbidity, and health care utilization in 163 subjects with borderline personality disorder.
    McCormick B; Blum N; Hansel R; Franklin JA; St John D; Pfohl B; Allen J; Black DW
    Compr Psychiatry; 2007; 48(5):406-12. PubMed ID: 17707247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.